Beast Industries Acquires Step, Expanding its Platform to Include Financial Services
9.2.2026 18:30:00 CET | Business Wire | Press Release
Beast Industries, the largest and most innovative creator based platform in the world, today announced the acquisition of Step, a financial technology company dedicated to making financial literacy and money management accessible to all.
This acquisition marks a significant milestone for Beast Industries, bringing together Step's robust technology platform and full-stack fintech team with Beast Industries’ extensive audience reach and proven track record in philanthropic initiatives. Together, the combined organization will deliver innovative solutions that make financial wellness achievable for people at every step of their life journey.
"Financial health is fundamental to overall wellbeing, yet too many people lack access to the tools and knowledge they need to build financial security," said Jeff Housenbold, CEO of Beast Industries. "This acquisition positions us to meet our audiences where they are, with practical, technology-driven solutions that can transform their financial futures for the better."
Step has built a reputation for combining intuitive technology with mission-driven values that align seamlessly with Beast Industries’ commitment to positive impact from tools and resources that educate customers on financial literacy to helping them establish and build healthy credit scores. Step’s mission and offerings have attracted over 7 million users and notable investors such as 4-time NBA Champion Stephen Curry, Social Media sensation Charli D’Amelio, Justin Timberlake, Will Smith and The Chainsmokers. Step, along with their experienced team, will accelerate Beast Industries’ ability to deliver comprehensive financial wellness solutions across its evolving platform.
"Our goal has always been to improve the financial future of the next generation,” said CJ MacDonald, CEO and Founder of Step. "There are a lot of synergies between Step and what Jimmy, Jeff and the team at Beast Industries believe in when it comes to helping people and giving back. We’re excited about how this acquisition is going to amplify our platform and bring more groundbreaking products to Step customers.”
This partnership recognizes the financial wellness challenges and opportunities to support people and communities throughout every stage of life. Together, Beast Industries and Step are focused on closing the financial literacy gap through innovation, technology, and philanthropic initiatives.
About Beast Industries
Beast Industries is a multifaceted entertainment, consumer products, and CPG company founded and led by YouTube creator, entrepreneur, and philanthropist Jimmy Donaldson, better known as MrBeast. A global entertainment powerhouse, MrBeast is the most-subscribed YouTube channel in the world with over 450 million subscribers and over 5 billion monthly views across all channels. Recognized as the #1 creator on Forbes' Top Creators List (2023) and featured on the TIME 100 and inaugural TIME100 Climate lists, Donaldson has built Beast Industries into a platform spanning groundbreaking content, record-breaking competition formats, and some of the fastest-growing CPG launches in history, including the snack brand Feastables. The company also drives large-scale social impact through initiatives like #TeamTrees, #TeamSeas, #TeamWater, and Beast Philanthropy, a 501(c)(3) nonprofit that has provided over 20 million free meals and funded critical infrastructure projects worldwide. At its core, Beast Industries blends entertainment, innovation, and purpose to create culturally resonant IP, market-leading products, and lasting change.
About Step
Step was founded by financial industry veterans CJ MacDonald and Alexey Kalinichenko to provide the next generation with financial tools for today’s modern-day banking needs and to promote financial literacy for the future. The founding team has 50+ years of combined financial technology experience from companies like First Data, Google, Gyft and Block. Step is backed by Coatue, Collaborative Fund, Crosslink Capital, General Catalyst and Stripe. Step’s financial products are powered by its bank partner Evolve Bank & Trust, Member FDIC and insured up to $1,000,000. To learn more, please visit: www.step.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260209810928/en/
Contacts
Media
mrbeast@hstrategies.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press Release
Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press Release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press Release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press Release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press Release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom